lorecivivint: Clinical Trials

3 trials of lorecivivint, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1

Follow lorecivivint: new trials by email Literature Review of lorecivivint trials Research Report on lorecivivint

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Lorecivivint (LOR), Triamcinolone acetonide (TA) - Drug-Drug Interaction
Phase 1CompletedBiosplice Therapeutics, Inc.402020-10-132021-01-12
A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease
SM04690 - Degenerative Disc Disease
Phase 1TerminatedBiosplice Therapeutics, Inc.62017-07-262019-04-23
Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA)
SM04690, 0.03mg/2mL, SM04690, 0.07mg/2mL, SM04690, 0.23mg/2mL - Moderate to Severe Osteoarthritis
Phase 1CompletedBiosplice Therapeutics, Inc.612014-03-012015-12-10

Conditions studied

Intervertebral Disc Degeneration (1)

Sponsors

Biosplice Therapeutics, Inc. (3)

Countries

United States (3)

Top investigators

Yusuf Yazici, M.D. (2)

Results publications

PMID 28711582, PMID 37902943